CA9 and neoplasm: Moreover, the real-time imaging of the expression of CA9, using a HypoxiSense 680 reporting fluorescent agent, was largely detected on tumors, and the fluorescent intensity became significantly stronger with the tumor growth based on the comparisons of tumor volume between week 1 and week 4 after tumor implantations.